HNO International, Inc.
HNOI
$0.97
$0.077.78%
| Weiss Ratings | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.90 | |||
| Price History | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.02% | |||
| 30-Day Total Return | -9.35% | |||
| 60-Day Total Return | 14.12% | |||
| 90-Day Total Return | 83.71% | |||
| Year to Date Total Return | -28.67% | |||
| 1-Year Total Return | -11.82% | |||
| 2-Year Total Return | -51.98% | |||
| 3-Year Total Return | -80.60% | |||
| 5-Year Total Return | -71.47% | |||
| 52-Week High % Change | -51.35% | |||
| 52-Week Low % Change | 445.79% | |||
| Price | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.85 | |||
| 52-Week Low Price | $0.16 | |||
| 52-Week Low Price (Date) | Mar 28, 2024 | |||
| 52-Week High Price (Date) | Jan 08, 2025 | |||
| Valuation | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 390.70M | |||
| Enterprise Value | 392.94M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -23.81% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -375.00 | |||
| Enterprise Value/Revenue (TTM) | 93,557.30 | |||
| Price | $0.97 | |||
| Enterprise Value/EBITDA (TTM) | -206.48 | |||
| Enterprise Value/EBIT | -192.35 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 410.59M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 951 305 8872 | |||
| Address | 4115 Eastman Drive Murrieta, CA 92562 | |||
| Website | www.hnointl.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -48,638.09% | |||
| Profit Margin | -49,133.33% | |||
| Management Effectiveness | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -80.16% | |||
| Return on Equity | -- | |||
| Income Statement | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.20K | |||
| Total Revenue (TTM) | 4.20K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -5.70K | |||
| EBITDA (TTM) | -1.90M | |||
| EBIT (TTM) | -2.04M | |||
| Net Income (TTM) | -2.06M | |||
| Net Income Avl. to Common (TTM) | -2.06M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -8.00% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -9.09% | |||
| Balance Sheet | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 78.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 78.90K | |||
| Total Preferred Equity (Q) | 0.01 | |||
| Total Equity (Q) | -984.70K | |||
| Current Ratio (Q) | 0.046 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 1.41M | |||
| Total Current Liabilities (Q) | 1.73M | |||
| Total Debt (Q) | 2.31M | |||
| Total Liabilities (Q) | 2.40M | |||
| Total Common Equity (Q) | -994.70K | |||
| Cash Flow | HNOI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.28M | |||
| Cash from Financing (TTM) | 2.04M | |||
| Net Change in Cash (TTM) | -1.15M | |||
| Levered Free Cash Flow (TTM) | -2.18M | |||
| Cash from Operations (TTM) | -1.91M | |||
